Patents by Inventor Donald Stribling

Donald Stribling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4977148
    Abstract: The invention concerns novel phenoxyacetic acid amide derivatives of the formula I (and pharmaceutically acceptable salts thereof) in which R.sup.1 is hydrogen or fluoro, R.sup.2 is phenyl, cycloalkyl, alkyl or alkenyl as defined herein, and R.sup.3 is hydrogen, methyl or ethyl, or R.sup.2 and R.sup.3 together form polymethylene as defined herein. The invention also includes pharmaceutical compositions containing the amide derivatives, means for the manufacture of the said derivatives and for their use in the treatment of obesity and related conditions and/or in the manufacture of novel medicaments.
    Type: Grant
    Filed: March 8, 1990
    Date of Patent: December 11, 1990
    Assignee: Imperial Chemical Industries
    Inventors: Brian R. Holloway, Ralph Howe, Balbir S. Rao, Donald Stribling
  • Patent number: 4937267
    Abstract: A method of treatment of obesity or diabetes mellitus in a warm-blooded animal requiring such treatment which comprises administering to said animal an effective amount of the compound N-(2-[2-hydroxy-3-phenoxypropyl]aminoethyl)-isobutyramide in racemic (R,S) or levorotatory optically active (S) form, or of a pharmaceutically acceptable acid-addition salt thereof.
    Type: Grant
    Filed: March 10, 1987
    Date of Patent: June 26, 1990
    Assignee: Imperial Chemical Industries PLC
    Inventors: Brian R. Holloway, Ralph Howe, Balbir S. Rao, Donald Stribling
  • Patent number: 4927836
    Abstract: The invention concerns novel phenoxyacetic acid amide derivatives of the formula I (and pharmaceutically acceptable salts thereof) in which R.sup.1 is hydrogen or fluoro, R.sup.2 is phenyl, cycloalkyl, alkyl or alkenyl as defined herein, and R.sup.3 is hydrogen, methyl or ethyl, or R.sup.2 and R.sup.3 together form polymethylene as defined herein. The invention also includes pharmaceutical compositions containing the amide derivatives, means for the manufacture of the said derivatives and for their use in the treatment of obesity and related conditions and/or in the manufacture of novel medicaments.
    Type: Grant
    Filed: June 29, 1988
    Date of Patent: May 22, 1990
    Assignee: Imperial Chemical Industries PLC
    Inventors: Brian R. Holloway, Ralph Howe, Balbir S. Rao, Donald Stribling
  • Patent number: 4789829
    Abstract: A method and apparatus for determining the shielding effectiveness of an RF gasket installed between two mating metallic surfaces of equipment or a structure by creating a time varying current flow from one of the mating surfaces to the other across the RF gasket, and sensing the current density of the time varying current in the vicinity of the gasket as a measure of shielding effectiveness. Two spaced electrodes, in the form of circular metal discs with a layer of dielectric material, are placed adjacent and substantially parallel to respective ones of the two metallic surfaces mated by the RF gasket with the gasket lying in the space between the electrodes. The electrodes are arranged to capacitively create a time varying current flow in the mating metallic surfaces between the electrodes. The current density in the metallic surfaces is sensed at a fixed position between the electrodes as a measure of gasket shielding effectiveness.
    Type: Grant
    Filed: July 18, 1986
    Date of Patent: December 6, 1988
    Assignee: Science Application International Corporation
    Inventor: Donald Stribling
  • Patent number: 4772631
    Abstract: The invention concerns a series of novel phenoxyacetic acid ethers (and pharmaceutically acceptable salts thereof) of the formula I in which R.sup.1 is H or F, R.sup.2 and R.sup.3 are H or (1-3C)alkyl, Z is CH.sub.2 OH or a group --CO.R.sup.4 in which R.sup.4 is OH, NH.sub.2 or (1-6C)alkoxy. The invention also includes pharmaceutical compositions for use in treating obesity and related conditions and provides processes for the manufacture of the novel ethers.
    Type: Grant
    Filed: July 28, 1986
    Date of Patent: September 20, 1988
    Assignee: Imperial Chemical Industries PlC
    Inventors: Brian R. Holloway, Ralph Howe, Balbir S. Rao, Donald Stribling